artesunate
Commercial- Indications
- Malaria
Company intelligence / Profile preview
Fosun Group
Shanghai, Shanghai, Chinaen.fosun.com ↗
- Ownership
- Private
- Employees
- ~40557
- Development stage
- Commercial
01
Overview
Fosun Pharma has a broad commercial portfolio with over 410 marketed drugs and more than 320 clinical trials. Its pipeline includes first-in-class and best-in-class new drugs across oncology, immunology, CNS disorders, infectious diseases (notably malaria), and chronic conditions. Notable achievements include the global impact of its antimalarial drug Artesunate for Injection ("Artesun"), biosimilars such as rituximab ("Han Li Kang") and trastuzumab ("Han Qu You"/"Zercepac"), as well as COVID diagnostics and vaccines. The company maintains strong R&D investment to drive innovation in both China and international markets.
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyNeurologyInfectious Diseases
- Modalities
- Small moleculeMonoclonal antibodyVaccinemRNA-based drugs
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sinopharm Co., Ltd. (major shareholder)Insilico Medicine partnership for AI-driven drug discovery in Chinavarious licensing/co-development deals
Beyond the preview
Go deeper on Fosun Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fosun Group.